On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary.
A whale with a lot of money to spend has taken a noticeably bearish stance on T-Mobile US.
Looking at options history for T-Mobile US (NASDAQ:TMUS) we detected 11 strange trades.
Qualcomm Inc (NASDAQ: QCOM) has been the previously unnamed partner in Iridium Communications Inc's (NASDAQ: IRDM) smartphone Technology Development Agreement and Service Provider Agreement.
Prominent market commentator Jim Cramer has recommended five stocks from the Nasdaq Index that he believes could be decent additions to investors’ portfolios.
RBC Capital analyst Kutgun Maral maintained Outperform on T-Mobile US, Inc (NASDAQ:TMUS) with a $166 price target after it shared preliminary 4Q22 subscriber…